WallStreetZenWallStreetZen

NASDAQ: ANGO
Angiodynamics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Angiodynamics revenue was $283.32M for the trailing 12 months ending Feb 28, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Feb 28, 2025 was $72.0M, down 1.2% from last quarter. For the last reported fiscal year 2024 ending May 31, 2024, ANGO annual revenue was $303.9M, with -10.3% growth year-over-year.

ANGO past revenue growth

How has ANGO's revenue growth performed historically?

Company
-12.56%
Industry
10.89%
Market
20.34%
ANGO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ANGO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
ANGO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

ANGO revenue history

Current Revenue
$283.3M
Current Earnings
-$41.4M
Current Profit Margin
-14.6%

Be the first to know when ANGO announces revenue.

ANGO Revenue History By Year

ANGO Yearly RevenueANGO RevenueANGO ChangeANGO Revenue Growth
2024-05-31$303.91M-$34.84M-10.28%
2023-05-31$338.75M$22.53M+7.13%
2022-05-31$316.22M$25.21M+8.66%
2021-05-31$291.01M$26.85M+10.17%
2020-05-31$264.16M-$6.48M-2.39%
2019-05-31$270.63M$8.98M+3.43%
2018-05-31$261.66M-$8.13M-3.01%
2017-05-31$269.79M-$84.10M-23.77%
2016-05-31$353.89M-$2.64M-0.74%
2015-05-31$356.53M$2.11M+0.60%
2014-05-31$354.43M$12.51M+3.66%
2013-05-31$341.92M$120.00M+54.07%
2012-05-31$221.92M$6.17M+2.86%
2011-05-31$215.75M-$285.00k-0.13%
2010-05-31$216.04M$20.98M+10.76%
2009-05-31$195.05M$28.55M+17.15%
2008-05-31$166.50M$54.27M+48.36%
2007-06-02$112.23M$33.78M+43.05%
2006-06-03$78.45M$18.16M+30.12%
2005-05-28$60.29M$11.23M+22.90%
2004-05-29$49.06M$10.62M+27.63%
2003-05-31$38.43M$7.54M+24.42%
2002-06-01$30.89M$7.50M+32.06%
2001-06-02$23.39MN/AN/A

1 of 2

Angiodynamics Revenue FAQ

What was ANGO's revenue last quarter?

On Invalid Date, Angiodynamics (NASDAQ: ANGO) reported Q1 2025 revenue of $72.00 million up 4.23% year over year. In the same quarter last year, Angiodynamics's revenue was $75.18 million.

What was Angiodynamics's revenue in 2024?

Angiodynamics's annual revenue for the twelve months ending May 31, 2024 was $303.91 million, a 10.28% decrease year over year.

How much does Angiodynamics make in a day?

Based on Angiodynamics annual revenue for the past five years, ANGO makes an average of $829,617.53 per day.

What was Angiodynamics's annual revenue growth in the past year?

As of Q2 2025, Angiodynamics's revenue has grown -12.56% year over year. This is 23.44 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 10.89%. Angiodynamics's revenue in the past year totaled $283.32 million.

How much does Angiodynamics make in a year?

Angiodynamics's revenue by year for the past five years is:
  • Angiodynamics's revenue for the twelve months ending May 31, 2024 was $303.91 million, a 10.28% decrease year over year.
  • Angiodynamics's annual revenue for May 31, 2023 was $338.75 million, a 7.13% increase from 2022.
  • Angiodynamics's annual revenue for 2022 was $316.22 million, a 8.66% increase from 2021.
  • Angiodynamics's annual revenue for 2021 was $291.01 million, a 10.17% increase from 2020.
  • Angiodynamics's annual revenue for 2020 was $264.16 million, a 2.39% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.